scholarly journals The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children

2016 ◽  
Vol 169 (2) ◽  
pp. 113-120 ◽  
Author(s):  
Deyu Zhao ◽  
Xuxin Lai ◽  
Man Tian ◽  
Yanhe Jiang ◽  
Yiwu Zheng ◽  
...  
Keyword(s):  
House Dust ◽  
House Dust Mite ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy ◽  
Blocking Factor ◽  
Dust Mite

Allergen‐specific immunotherapy boosts allergen‐specific IgD production in house dust mite‐sensitized asthmatic patients

Allergy ◽  
2020 ◽  
Vol 75 (6) ◽  
pp. 1457-1460 ◽  
Author(s):  
Tadech Boonpiyathad ◽  
Panitan Pradubpongsa ◽  
Wat Mitthamsiri ◽  
Pattraporn Satitsuksanoa ◽  
Alain Jacquet ◽  
...  
Keyword(s):  
House Dust ◽  
House Dust Mite ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy ◽  
Asthmatic Patients ◽  
Dust Mite

Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis

2017 ◽  
Vol 131 (11) ◽  
pp. 997-1001 ◽  
Author(s):  
E Sahin ◽  
D Dizdar ◽  
M E Dinc ◽  
A A Cirik
Keyword(s):  
Allergic Rhinitis ◽  
House Dust ◽  
House Dust Mite ◽  
Specific Immunotherapy ◽  
Subcutaneous Immunotherapy ◽  
Long Term Effects ◽  
Allergen Specific Immunotherapy ◽  
Dust Mite ◽  
Symptom Scores

AbstractBackground:Allergic rhinitis is strongly associated with the presence of house dust mites. This study investigated the long-term effects of allergen-specific immunotherapy. Allergen-specific immunotherapy was applied over three years. The study was based on a 10-year follow up of patients with allergic rhinitis.Methods:The study was conducted between 2001 and 2015. Skin prick test results and symptom scores were evaluated before (26 patients) and after 3 years (20 patients) of allergen-specific immunotherapy (using data from a previously published study), and 10 years after allergen-specific immunotherapy had ended (20 of 26 patients).Results:The symptom scores before allergen-specific immunotherapy were significantly higher than those obtained after 3 years of allergen-specific immunotherapy and 10 years after allergen-specific immunotherapy (p < 0.0175). There were no significant differences between the scores obtained at 3 years and 10 years after allergen-specific immunotherapy (p > 0.0175).Conclusion:Subcutaneous immunotherapy is an effective treatment for house dust mite induced allergic rhinitis.

Serological responses to house dust mite antigens in atopic dogs while receiving allergen-specific immunotherapy

2002 ◽  
Vol 13 (4) ◽  
pp. 211-229 ◽  
Author(s):  
A. P. Foster ◽  
H. A. Jackson ◽  
K. Stedman ◽  
T. G. Knowles ◽  
M. J. Day ◽  
...  
Keyword(s):  
House Dust ◽  
House Dust Mite ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy ◽  
Dust Mite
Sign in / Sign up

Export Citation Format

Share Document